North America Travel Vaccines Market to Reach USD 3.24 Billion by 2033, Stimulated by Increasing Outbound Tourism and International Business Activities

March 18, 2025 | Healthcare

According to the latest report by IMARC Group, titled “North America Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Country 2025-2033,” the North America travel vaccines market size reached USD 2.01 Billion in 2024. Travel Vaccines are specialized immunizations designed to protect individuals from infectious diseases that may be prevalent in foreign countries or regions. When people travel internationally, they may encounter health risks that differ from those in their home country. Travel vaccines offer crucial protection by stimulating the body's immune system to produce antibodies against specific diseases, preventing infection and potential health complications. These vaccines are tailored to address the unique risks associated with different travel destinations, considering factors such as the traveler's health status, destination, and stay duration. The primary objective of travel vaccines is to safeguard travelers' health and well-being during their journeys and prevent the spread of infectious diseases across borders.

North America Travel Vaccines Market Trends:

The rising awareness among travelers about the importance of pre-travel health preparations as more individuals embark on international trips for leisure, business, or educational purpose are some of the major factors driving the market growth. Travel vaccines safeguard individuals’ health, thus ensuring a seamless travel experience. Additionally, the increasing cross-border trade in North America as companies expand their operations internationally, propelling companies to implement pre-travel health programs recommending employees to get appropriate travel vaccines, is positively impacting the market growth. Moreover, the rising need for specialized vaccines catering to specific travel destinations has encouraged pharmaceutical companies to invest in research and development (R&D) efforts to create vaccines that meet these concerns, further offering comprehensive protection and boosting travelers' confidence. Furthermore, rapid advancements in medical technology and vaccine development leading to the introduction of combination vaccines that offer protection against multiple diseases with a single shot, streamlining the vaccination process for travelers, is favoring the market growth. Besides this, the increasing prevalence of private travel clinics and specialized travel healthcare providers in the region offering personalized pre-travel consultations, where healthcare professionals assess travelers' health risks and recommend appropriate vaccines and preventive measures, is providing remunerative growth opportunities. Looking forward, the market value is projected to reach USD 3.24 Billion by 2033, expanding at a CAGR of 5.5% during 2025-2033.

Market Summary:

  • Based on the composition, the market has been segmented as mono and combination vaccines.
  • On the basis of the disease, the market has been divided into hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others.
  • Region-wise, the market has been segmented into the United States, Canada, and Mexico.
  • The competitive landscape of the market has also been examined along with the profiles of the key players.

Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Composition, Disease, Country
Countries Covered United States, Canada, Mexico
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
North America Travel Vaccines Market to Reach USD 3.24 Billion by 2033, Stimulated by Increasing Outbound Tourism and International Business Activities
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials